Health Plans Archives

Julie Kaylor, M.S., CGC, Client Executive|May 26, 2020June 3, 2020
Clinical Health Plans Health Systems

4 Ways Genetic Analyst Reviews Benefit Genetic Test Prior Authorization Requests

David Nixon, CEO|April 30, 2020May 8, 2020
Health Plans Health Systems Our Take

Leveling the Playing Field in Genetic Medicine Requires Hands-On Expertise at the Point of Care

Rebecca Sutphen, MD, FACMGG, Chief Medical Officer|March 20, 2020
Clinical Health Plans Health Systems Life Sciences

Tele-genetic Counseling and Testing Services Still Available Nationwide During the COVID-19 Health Crisis

Kelly Athman, M.S., CGC; Megan Czarniecki, M.S., M.A., CGC; Shanna Gustafson M.S., CGC; Julie Kaylor M.S., CGC|March 11, 2020March 19, 2020
Clinical Health Plans Our Take

InformedDNA Approach to Utilization Management Addresses Concerns Expressed by AMA Consensus Statement

Whitney Ducaine, MGC, CGC, CN-BM, Director, Cancer Genetics Services; Shannon Morrill-Cornelius, MS, CGC, Genetic Analyst|February 17, 2020March 11, 2020
Health Plans Health Systems Our Take

NCCN Updates for Hereditary Breast and Ovarian Cancer Genetic Testing: Implications for Patients, Providers, and Health Plans

InformedDNA|November 27, 2019December 3, 2019
Health Plans Original Research & Analysis

Original Research & Analysis: Informed Insights, issue two

David Nixon, CEO; Heather Dorsey, MS, CGC, Evidence Review Manager|October 29, 2019November 6, 2019
Health Plans Life Sciences

Bridging Genetic Benefits Management^TM to Precision Medicine Management^TM

Virginia Anne Adams, M.S., CGC, Genetic Counselor; Rachel Barnett, M.S., CGC, Assistant Cancer Team Lead; Julie Kaylor, M.S., CGC, Client Executive; Tricia See, ScM, CGC, Cardiac & Neurogenetics Team Lead|October 22, 2019October 30, 2019
Clinical Health Plans Health Systems

Blog

4 Ways Genetic Analyst Reviews Benefit Genetic Test Prior Authorization Requests

Leveling the Playing Field in Genetic Medicine Requires Hands-On Expertise at the Point of Care

Tele-genetic Counseling and Testing Services Still Available Nationwide During the COVID-19 Health Crisis

InformedDNA Approach to Utilization Management Addresses Concerns Expressed by AMA Consensus Statement

NCCN Updates for Hereditary Breast and Ovarian Cancer Genetic Testing: Implications for Patients, Providers, and Health Plans

Original Research & Analysis: Informed Insights, issue two

Bridging Genetic Benefits Management^TM to Precision Medicine Management^TM

Insights and Considerations for Large Panel Genetic Tests

Original Research & Analysis: Informed Insights, issue one

Reducing Genetic Test Complexity, Confusion and High Costs Through a Condition-Specific Approach to Policy Coverage

Let's talk about your genetic services needs.

Blog

Let's talk about your genetic services needs.

Schedule a Genetic Counseling Appointment